Prostaglandin Associated Periorbitopathy - EyeWiki
Prostaglandin Associated Periorbitopathy (PAP) is the general term given to describe the constellation of eyelid and orbital changes that accompany the administration of topical prostaglandin analogue eye drops.
Prostaglandin-Associated Periorbitopathy - University of Iowa
2013年10月14日 · In addition, they may be associated with anterior uveitis, cystoid macula edema and reactivation of herpetic eye disease, although these lack a direct causal relationship with the medication.(4) More recently, a constellation of changes referred to as prostaglandin-associated periorbitopathy (PAP) has been associated with the use of PGAs.(5, 6 ...
What Clinicians Need to Know About Prostaglandin-Associated Periorbitopathy
2012年3月1日 · These potential side effects include ptosis, relative enophthalmos, inferior scleral show, periorbital fat atrophy and involution of dermatochalasis (see “Characteristics of PAP”).
Prostaglandin-associated periorbitopathy syndrome (PAPS): Addressing …
2021年11月18日 · Defining Prostaglandin-associated Periorbitopathy Syndrome (PAPS) The progressive optic neuropathy associated with glaucoma results in loss of visual acuity and constriction of visual fields. Topical prostaglandin analogs (PGAs) are widely approved and preferred as a first-line treatment option for the management of glaucoma and ocular ...
Prostaglandin-associated periorbitopathy syndrome (PAPS): …
2022年5月19日 · Background: Topical prostaglandin analogs (PGAs) are widely approved and preferred first-line options for glaucoma and elevated intraocular pressure (IOP). However, prostaglandin-associated periorbitopathy syndrome (PAPS) is now a well-recognized clinical and cosmetic concern for patients receiving PGAs, especially during long-term and ...
Prostaglandin-associated periorbitopathy - PMC
He presented with deepening of superior sulcus (arrow), periorbital fat atrophy, mild ptosis (a), and 2 mm of enophthalmos (b) in his left eye , which are typically seen in prostaglandin-associated periorbitopathy (PAP). Comparison with old photographs taken before topical bimatoprost use showed the absence of any asymmetry between the eyes.
IOP: intraocular pressure; PAPS: prostaglandin-associated. Patients are advised to carefully clean any excess eyedrops from the periorbital area. Practical recommendations may include:1. 1. Inoue. Clin Ophthalmol 2014;8:903–13; 2. PAPS Compendium Expert Advisory Meeting, 23rd July, 2022; 3. Asia-Pacific Glaucoma Society.
Prostaglandin-associated periorbitopathy - Medsafe
2022年9月1日 · Prostaglandin-associated periorbitopathy (PAP) has been associated with the use of ocular prostaglandin analogues. Before initiating treatment, inform patients of the possibility of changes to the eye during treatment.
[Prostaglandin-associated periorbitopathy] - PubMed
2017年8月11日 · As people pay more attention to appearance, periorbitopathy caused by prostaglandin has been reported in recent years, including upper eyelid ptosis and dermatochalasis, deepening of the upper eyelid sulcus, periorbital fat loss, enophthalmos and inferior scleral exposure.
Clinical Staging of Prostaglandin-Associated Periorbitopathy …
2024年6月6日 · Topical prostaglandin analogues are commonly used to treat patients with glaucoma, but may cause periocular and periorbital complications known as prostaglandin-associated periorbitopathy syndrome (PAPS). A literature review was conducted on PAPS.